4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000018
PRESIDENT AND COO sold 22,500 shares at $502.79 ($11,312,710)
- PRESIDENT AND COO acquired 14,625 shares (option exercise)
- PRESIDENT AND COO acquired 7,875 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-29 | Exercise or conversion : show line 1 in the form 10b5-1 | −14,625 | $117.76 | $1,722,240 | 14,625 | I |
| 2025-12-29 | Sale : show line 2 in the form 10b5-1 | −14,625 | $502.79 | $7,353,261 | 0 | I |
| 2025-12-29 | Exercise or conversion : show line 3 in the form 10b5-1 | +7,875 | $146.03 | $1,149,986 | 7,875 | I |
| 2025-12-29 | Sale : show line 4 in the form 10b5-1 | −7,875 | $502.79 | $3,959,448 | 0 | I |
| Open-market sales · 22,500 sh · avg $502.79 · $11,312,710 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-29 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Options | −14,625 | 111,750 | I |
| 2025-12-29 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Options | −7,875 | 60,190 | I |
Loading xslF345X05/primarydocument.xml…